Facebook
Twitter
Home 
How Blumble Works 
Search Algorithm 
Your Privacy 
About 
Blog
Biospace news
Alzheon Announces Appointment of Renowned Biopharma Executive Gino Santini to Board of Directors. 6/12/2024. Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Trends
Sana Downsizes Staff by 29%, Refocuses on Ex Vivo Cell Therapy Platform. 10/11/2023. The biotech is laying off about 29% of its employees and will focus its resources on the company's hypoimmune platform. The latest downsizing follows a previous round...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Hematology/Oncology: AOP Health's Expanding Clinical Research Program Delivers New Results. 6/10/2024. AOP Orphan Pharmaceuticals GmbH continues a successful clinical research program in hematology/oncology with two abstracts accepted for presentation...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American. 6/7/2024. NovaBay® Pharmaceuticals, Inc. announces that the NYSE American LLC has accepted the Company's plan to regain compliance with NYSE American's continued listing standards.
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
WARREN, N.J., June 12, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Sana Downsizes Staff by 29%, Refocuses on Ex Vivo Cell Therapy Platform. 10/11/2023. The biotech is laying off about 29% of its employees and will focus its resources on the company's hypoimmune platform. The latest downsizing follows a previous...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
6/10/2024. Biophytis SA, a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, announces that it has submitted an Investigational New Drug application with the U.S. Food and Drug Administration...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
BioSpace is proud to present its NextGen Bio Class of 2024, a list of the hottest new life sciences companies in the United States. To come up with this list, BioSpace identified companies that launched between September 2022 and September 2023 with...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Patients with Acute Babesiosis. 6/11/2024. 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the "Company" or "60 Degrees...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Published: Jun 12, 2024. LA JOLLA, Calif.-- ( BUSINESS WIRE )-- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it...
- Safe
- Ireland
- Encrypted
- 29 yrs old
- 11,518 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
WEBSITE REPORT CARD
-
![]()
Norton safe Web
-
McAfee Web Advisor
-
Site is
-
Hosted in
-
-
Traffic rank:
-
Site age:
-
Site Owner information
Norton safe Web